LYFAX Mutual Fund

LYFAX Mutual Fund

NAV$18.86
See how much of LYFAX you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
$5M
Expense Ratio
1.71%
Dividend Yield (Current)
1.26%
Holdings
63
Inception Date
Nov 29, 2019
Fund Family
Alpha Centric Fund
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+13.38%
1 Year+50.69%
3 Year+9.43%
5 Year+9.85%

Asset Allocation

Stocks: 92.29%
Cash: 7.71%
See how much of LYFAX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
FXFXXFirst Am Treas Obli-X7.72%
GILDGilead Sciences7.18%
AZN:LNAstrazeneca Plc5.63%
VRTXNvaesrtex Pharmaceuticals Inc5.60%
IONSIonis Pharmaceuticals Inc3.74%
Top 10 Concentration: 46.76%Report Date: Mar 31, 2026
Download all 63 holdings for LYFAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.26%
Frequency
Annually
Latest Distribution
$1.65
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

LYFAX Mutual Fund Overview

LYFAX Mutual Fund (AlphaCentric Life Sciences and Healthcare Fund Class A) is managed by Alpha Centric Fund with $4.9M in net assets. LYFAX expense ratio is 1.71%, holding 63 positions across sectors including Health Care, Financials. Inception date: 2019-11-29.

LYFAX performance shows a YTD return of 13.38%. The 1-year return is 50.69% and the 5-year return is 9.85%. LYFAX dividend yield stands at 1.26%, paid annually.

LYFAX top holdings include First Am Treas Obli-X (7.7%), Gilead Sciences (7.2%), Astrazeneca Plc (5.6%), Nvaesrtex Pharmaceuticals Inc (5.6%), Ionis Pharmaceuticals Inc (3.7%). Go to all LYFAX holdings, LYFAX sectors, or LYFAX dividends.

LYFAX can be compared against other funds. Use LYFAX overlap to find shared positions, or LYFAX vs another fund for a side-by-side view. LYFAX alternatives are available via the screener, along with tax-loss harvesting opportunities.